Skip to Main Content

Paper Details

Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection.
Cancer Prev Res (Phila)
0
2023
CD4, CD4+, CD8, CD8+, Chronic Hepatitis C Virus (HCV) Infection, Chronic hepatitis C, DNA-encoding, HCV, HCV-infected, HCV-specific CD4+ and CD8+ T cells, Hepatocellular Carcinoma, IFN, IL12, IL12 DNA, INO, INO-8000, INO-9012, NS3, NS4A, NS4B, NS5A proteins, chronic hepatitis, chronic hepatitis C, cirrhosis, hepatitis, hepatitis C, hepatitis C viral, hepatitis C viral antigen DNA vaccine, hepatocellular carcinoma, human, participants
Author NameAffiliation
Jeffrey M JacobsonCase Western Reserve University
Lewis R RobertsMayo Clinic
David B WeinerWistar Institute
  • 1 - 3

Datasets

Release 1.2